Q32K (p.Gln32Lys) variant of RYR2 (Ryanodine receptor 2)

Q32K (p.Gln32Lys) in RYR2 (Ryanodine receptor 2) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.63 / 1. The record also includes population frequency data, published literature, and structural context.

Q32K (p.Gln32Lys) variant details